Literature for rupintrivir (C03.007 inhibitor)

(Topics flags: S Structure, A Assay, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2020
1. Yuan,S., Fan,K., Chen,Z., Sun,Y., Hou,H. and Zhu,L.
   Structure of the HRV-C 3C-rupintrivir complex provides new insights for inhibitor design
   Virol Sin35, 445-454. PubMed  Europe PubMed DOI  I
2018
2. Kitano,M., Hosmillo,M., Emmott,E., Lu,J. and Goodfellow,I.
   Selection and characterization of rupintrivir-resistant Norwalk virus replicon cells in vitro
   Antimicrob Agents Chemother62, e00201-18-e00201-18. PubMed  Europe PubMed DOI  A  I
2016
3. Ang,M.J., Lau,Q.Y., Ng,F.M., Then,S.W., Poulsen,A., Cheong,Y.K., Ngoh,Z.X., Tan,Y.W., Peng,J., Keller,T.H., Hill,J., Chu,J.J. and Brian Chia,C.S.
   Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study
   J Enzyme Inhib Med Chem31, 332-339. PubMed  Europe PubMed DOI  I
4. Jetsadawisut,W., Nutho,B., Meeprasert,A., Rungrotmongkol,T., Kungwan,N., Wolschann,P. and Hannongbua,S.
   Susceptibility of inhibitors against 3C protease of coxsackievirus A16 and enterovirus A71 causing hand, foot and mouth disease: a molecular dynamics study
   Biophys Chem219, 9-16. PubMed  Europe PubMed DOI  I
5. Kawatkar,S.P., Gagnon,M., Hoesch,V., Tiong-Yip,C., Johnson,K., Ek,M., Nilsson,E., Lister,T., Olsson,L., Patel,J. and Yu,Q.
   Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease
   Bioorg Med Chem Lett26, 3248-3252. PubMed  Europe PubMed DOI  S  I
2014
6. Tam,J.C., Bidgood,S.R., McEwan,W.A. and James,L.C.
   Intracellular sensing of complement C3 activates cell autonomous immunity
   Science345, 1256070-1256070. PubMed  Europe PubMed DOI  I
7. van der Linden,L., Ulferts,R., Nabuurs,S.B., Kusov,Y., Liu,H., George,S., Lacroix,C., Goris,N., Lefebvre,D., Lanke,K.H., De Clercq,K., Hilgenfeld,R., Neyts,J. and van Kuppeveld,F.J.
   Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases
   Antiviral Res103, 17-24. PubMed  Europe PubMed DOI  I
2013
8. Wu,C., Cai,Q., Chen,C., Li,N., Peng,X., Cai,Y., Yin,K., Chen,X., Wang,X., Zhang,R., Liu,L., Chen,S., Li,J. and Lin,T.
   Structures of enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir
   Acta Crystallogr D Biol Crystallogr69, 866-871. PubMed  Europe PubMed DOI  S  I
2011
9. Costenaro,L., Kaczmarska,Z., Arnan,C., Janowski,R., Coutard,B., Sola,M., Gorbalenya,A.E., Norder,H., Canard,B. and Coll,M.
   Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93
   J Virol85, 10764-10773. PubMed  Europe PubMed DOI  S  I
2005
10. Binford,S.L., Maldonado,F., Brothers,M.A., Weady,P.T., Zalman,L.S., Meador,J.W., III, Matthews,D.A. and Patick,A.K.
    Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor
    Antimicrob Agents Chemother49, 619-626. PubMed  Europe PubMed DOI  I
11. [YEAR:30-6-2005]Shie,J.J., Fang,J.M., Kuo,T.H., Kuo,C.J., Liang,P.H., Huang,H.J., Wu,Y.T., Jan,J.T., Cheng,Y.S. and Wong,C.H.
    Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters
    Bioorg Med Chem13, 5240-5252. PubMed  Europe PubMed DOI  I
2003
12. [YEAR:15-8-2003]Chou,K.C., Wei,D.Q. and Zhong,W.Z.
    Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS
    Biochem Biophys Res Commun308, 148-151. PubMed  Europe PubMed DOI  S  I
2001
13. [YEAR:24-9-2001]Tian,Q.P., Nayyar,N.K., Babu,S., Chen,L.J., Tao,J.H., Lee,S., Tibbetts,A., Moran,T., Liou,J., Guo,M. and Kennedy,T.P.
    An efficient synthesis of a key intermediate for the preparation of the rhinovirus protease inhibitor AG7088 via asymmetric dianionic cyanomethylation of N-Boc-L-(+)-glutamic acid dimethyl ester
    Tetrahedron Lett42, 6807-6809.  I
14. Zhang,K.E., Hee,B., Lee,C.A., Liang,B. and Potts,B.C.
    Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease
    Drug Metab Dispos29, 729-734. PubMed  Europe PubMed  I
2000
15. Zalman,L.S., Brothers,M.A., Dragovich,P.S., Zhou,R., Prins,T.J., Worland,S.T. and Patick,A.K.
    Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor
    Antimicrobial Agents Chemother44, 1236-1241. PubMed  Europe PubMed DOI  I
1999
16. [YEAR:28-9-1999]Matthews,D.A., Dragovich,P.S., Webber,S.E., Fuhrman,S.A., Patick,A.K., Zalman,L.S., Hendrickson,T.F., Love,R.A., Prins,T.J., Marakovits,J.T., Zhou,R., Tikhe,J., Ford,C.E., Meador,J.W., Ferre,R.A., Brown,E.L., Binford,S.L., Brothers,M.A., DeLisle,D.M. and Worland,S.T.
    Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes
    Proc Natl Acad Sci U S A96, 11000-11007. PubMed  Europe PubMed DOI  I
17. Patick,A.K., Binford,S.L., Brothers,M.A., Jackson,R.L., Ford,C.E., Diem,M.D., Maldonado,F., Dragovich,P.S., Zhou,R., Prins,T.J., Fuhrman,S.A., Meador,J.W., Zalman,L.S., Matthews,D.A. and Worland,S.T.
    In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease
    Antimicrobial Agents Chemother43, 2444-2450. PubMed  Europe PubMed  I